Sakai, Kazuko <br/><br/>
Targeted DNA and RNA sequencing of fine-needle biopsy FFPE specimens in patients with unresectable hepatocellular carcinoma treated with sorafenib.  [electronic resource] 

 -  Oncotarget  Aug 2015 
 - 21636-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.4270  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Biomarkers--metabolism<br/>Biomarkers, Tumor--metabolism<br/>Biopsy, Fine-Needle<br/>Carcinoma, Hepatocellular--drug therapy<br/>Female<br/>Formaldehyde--chemistry<br/>Gene Expression Profiling<br/>Gene Expression Regulation, Neoplastic<br/>High-Throughput Nucleotide Sequencing--methods<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mutation<br/>Neuregulin-1--genetics<br/>Niacinamide--analogs & derivatives<br/>Paraffin Embedding<br/>Phenylurea Compounds--therapeutic use<br/>Platelet Endothelial Cell Adhesion Molecule-1--genetics<br/>Sequence Analysis, DNA<br/>Sequence Analysis, RNA<br/>Sorafenib<br/>Transforming Growth Factor alpha--genetics<br/>Treatment Outcome<br/>Tumor Suppressor Protein p53--genetics<br/>beta Catenin--genetics